Eric Dobmeier, COO at Seagen, holds 563.33K shares in Atara Biotherapeutics (Ticker: ATRA), holds 0.00 shares in Chinook Therapeutics (Ticker: KDNY), holds 1.50K shares in Adaptive Biotechnologies (Ticker: ADPT). Most recently, Eric Dobmeier Bought ― shares of Atara Biotherapeutics on Nov 14, 2023 for an estimated value of 98.30K.